Literature DB >> 5017378

Failure of sulfonylureas to suppress plasma glucagon in man.

S Pek, S S Fajans, J C Floyd, R F Knopf, J W Conn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5017378     DOI: 10.2337/diab.21.4.216

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  7 in total

1.  Plasma glucagon in insulinoma.

Authors:  A Ohneda; K Matsuda; K Horigome; S Ishii; A Yanbe; Y Maruhama
Journal:  Acta Diabetol Lat       Date:  1977 Sep-Dec

2.  Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations.

Authors:  F Gregorio; F Ambrosi; S Cristallini; P Filipponi; F Santeusanio
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 3.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

4.  Modelling the electrical activity of pancreatic alpha-cells based on experimental data from intact mouse islets.

Authors:  Paul M Diderichsen; Sven O Göpel
Journal:  J Biol Phys       Date:  2006-11-09       Impact factor: 1.365

5.  Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect.

Authors:  C G Ostenson; A Nylén; V Grill; M Gutniak; S Efendić
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

6.  [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)].

Authors:  G Baumeister; H Wagner; M Stahl
Journal:  Klin Wochenschr       Date:  1975-06-15

7.  Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.

Authors:  J L Cohen; A Vinik; J Faller; I H Fox
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.